These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7049371

  • 1. Clinical pharmacology and pharmacokinetics of cis-platinum and analogs.
    Ribaud P, Gouveia J, Bonnay M, Mathe G.
    Cancer Treat Rep; 1981; 65 Suppl 3():97-105. PubMed ID: 7049371
    [Abstract] [Full Text] [Related]

  • 2. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 3. Rationale for development of platinum analogs.
    Burchenal JH, Kalaher K, Dew K, Lokys L.
    Cancer Treat Rep; 1979 Nov; 63(9-10):1493-8. PubMed ID: 498148
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH, Steerenberg PA, Vos JG, Bulten EJ, Verbeek F, Kruizinga W, Ruitenberg EJ.
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.
    Cano JP, Catalin J, Rigault JP, Bues-Charbit M, Placidi M, Raybaud C, Bernard JL.
    Biomedicine; 1981 Dec; 34(3):146-53. PubMed ID: 7199945
    [Abstract] [Full Text] [Related]

  • 6. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL, Dedon PC, Keng PC, Katz JC, Borch RF.
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [Abstract] [Full Text] [Related]

  • 7. Platinum analogs of clinical interest.
    Hill JM, Loeb E, Pardue A, Khan A, King JJ, Aleman C, Hill NO.
    Cancer Treat Rep; 1979 Jun; 63(9-10):1509-13. PubMed ID: 291481
    [Abstract] [Full Text] [Related]

  • 8. Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).
    Kelsen DP, Scher H, Alcock N, Leyland-Jones B, Donner A, Williams L, Greene G, Burchenal JH, Tan C, Philips FS, Young CW.
    Cancer Res; 1982 Nov; 42(11):4831-5. PubMed ID: 7127319
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
    Schmittgen TD, Ju JF, Danenberg KD, Danenberg PV.
    Int J Oncol; 2003 Sep; 23(3):785-9. PubMed ID: 12888918
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of Malonato (1,2 diaminocyclohexane) platinum.
    Kelsen DP, Ribaud P, Alcock N, Burchenal JH, Young CW, Mathe G.
    Cancer Clin Trials; 1981 Sep; 4(4):429-31. PubMed ID: 7318125
    [Abstract] [Full Text] [Related]

  • 11. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH, Thai G, Yoshida M, Zhang YP, Khokhar AR.
    Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
    [Abstract] [Full Text] [Related]

  • 12. High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.
    Ostrow S, Egorin M, Aisner J, Bachur N, Wiernik PH.
    Cancer Clin Trials; 1980 Dec; 3(1):23-7. PubMed ID: 7190082
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
    Fracasso ME, Apostoli P, Benoni G, Bonetti A, Griso C, Leone R.
    Drugs Exp Clin Res; 1987 Dec; 13(6):367-72. PubMed ID: 3652926
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of cis-diamminedichloroplatinum (II) given as low-dose and high-dose infusions.
    Kurihara N, Kubota T, Hoshiya Y, Otani Y, Ando N, Kumai K, Kitajima M.
    J Surg Oncol; 1996 Jun; 62(2):135-8. PubMed ID: 8649040
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
    Specenier PM, Ciuleanu T, Latz JE, Musib LC, Darstein CL, Vermorken JB.
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):233-41. PubMed ID: 19011858
    [Abstract] [Full Text] [Related]

  • 16. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Sep 01; 54(17):4691-7. PubMed ID: 8062266
    [Abstract] [Full Text] [Related]

  • 17. Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia.
    Fulco RA, Vannozzi M, Collecchi P, Merlo F, Parodi B, Civalleri D, Esposito M.
    Anticancer Res; 1990 Sep 01; 10(6):1603-10. PubMed ID: 2285232
    [Abstract] [Full Text] [Related]

  • 18. Satraplatin: an orally available platinum analog for the treatment of cancer.
    Choy H.
    Expert Rev Anticancer Ther; 2006 Jul 01; 6(7):973-82. PubMed ID: 16831070
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C, Huang R, Lian L.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar 01; 31(3):159-62. PubMed ID: 8758790
    [Abstract] [Full Text] [Related]

  • 20. A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.
    Rademaker-Lakhai JM, Terret C, Howell SB, Baud CM, De Boer RF, Pluim D, Beijnen JH, Schellens JH, Droz JP.
    Clin Cancer Res; 2004 May 15; 10(10):3386-95. PubMed ID: 15161693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.